Silvercrest Asset Management Group Cut By $407,616 Its Abbvie Com (ABBV) Stake; Mannkind (MNKD) Shorts Raised By 1.19%

April 21, 2018 - By Nellie Frank

MannKind Corporation (NASDAQ:MNKD) Logo

Mannkind Corporation (NASDAQ:MNKD) had an increase of 1.19% in short interest. MNKD’s SI was 35.94 million shares in April as released by FINRA. Its up 1.19% from 35.52M shares previously. With 1.48 million avg volume, 24 days are for Mannkind Corporation (NASDAQ:MNKD)’s short sellers to cover MNKD’s short positions. The SI to Mannkind Corporation’s float is 37.98%. The stock decreased 5.03% or $0.09 during the last trading session, reaching $1.7. About 3.66 million shares traded. MannKind Corporation (NASDAQ:MNKD) has risen 37.36% since April 21, 2017 and is uptrending. It has outperformed by 25.81% the S&P500.

Silvercrest Asset Management Group Llc decreased Abbvie Inc Com (ABBV) stake by 1.93% reported in 2017Q4 SEC filing. Silvercrest Asset Management Group Llc sold 4,246 shares as Abbvie Inc Com (ABBV)’s stock declined 6.31%. The Silvercrest Asset Management Group Llc holds 215,212 shares with $20.81 million value, down from 219,458 last quarter. Abbvie Inc Com now has $146.93B valuation. The stock decreased 0.44% or $0.41 during the last trading session, reaching $92.6. About 4.75 million shares traded. AbbVie Inc. (NYSE:ABBV) has risen 39.20% since April 21, 2017 and is uptrending. It has outperformed by 27.65% the S&P500.

Investors sentiment decreased to 0.8 in Q4 2017. Its down 0.05, from 0.85 in 2017Q3. It fall, as 42 investors sold ABBV shares while 695 reduced holdings. 139 funds opened positions while 448 raised stakes. 1.06 billion shares or 0.35% more from 1.06 billion shares in 2017Q3 were reported. Atria Limited Liability reported 0.24% of its portfolio in AbbVie Inc. (NYSE:ABBV). Wealthfront reported 80,157 shares stake. Pnc Grp Inc accumulated 0.49% or 5.24M shares. Lagoda Inv Mngmt Ltd Partnership reported 489 shares or 0.02% of all its holdings. Supplemental Annuity Collective Trust Of Nj invested 0.53% in AbbVie Inc. (NYSE:ABBV). Nippon Life Insurance accumulated 255,400 shares. Bryn Mawr, Pennsylvania-based fund reported 39,398 shares. Hills Fincl Bank Company reported 3,824 shares stake. Guggenheim Ltd Com has 0.4% invested in AbbVie Inc. (NYSE:ABBV) for 1.74 million shares. Intrust Bankshares Na stated it has 15,401 shares. Prudential has invested 0.71% of its portfolio in AbbVie Inc. (NYSE:ABBV). 39,958 are owned by Tnb. Edmp has invested 2.97% in AbbVie Inc. (NYSE:ABBV). 2,255 were reported by Shufro Rose And Com Ltd Com. North American Management stated it has 11,408 shares or 0.17% of all its holdings.

Since October 30, 2017, it had 0 insider purchases, and 12 sales for $49.35 million activity. On Wednesday, February 28 the insider CHASE WILLIAM J sold $8.31 million. 87,040 shares valued at $8.57 million were sold by RICHMOND TIMOTHY J. on Monday, December 18. The insider Michael Robert A. sold $119,351. SEVERINO MICHAEL sold 2,643 shares worth $311,684. ALBAN CARLOS sold 83,574 shares worth $9.57 million. The insider SALEKI-GERHARDT AZITA sold $157,458. GONZALEZ RICHARD A sold 8,280 shares worth $976,084.

Among 23 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 11 Hold. Therefore 43% are positive. Abbvie Inc had 89 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Sunday, October 29 by SunTrust. The firm earned “Buy” rating on Wednesday, July 22 by SunTrust. The company was downgraded on Wednesday, June 8 by Morgan Stanley. The stock has “Hold” rating by Credit Suisse on Thursday, July 20. As per Sunday, July 30, the company rating was maintained by BMO Capital Markets. Cowen & Co maintained the stock with “Hold” rating in Friday, July 28 report. The stock has “Neutral” rating by Atlantic Securities on Friday, December 18. Leerink Swann maintained the stock with “Buy” rating in Tuesday, December 5 report. The rating was maintained by BMO Capital Markets on Friday, March 23 with “Underperform”. On Monday, November 20 the stock rating was maintained by Cowen & Co with “Buy”.

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on April, 26 before the open. They expect $1.78 earnings per share, up 39.06% or $0.50 from last year’s $1.28 per share. ABBV’s profit will be $2.82 billion for 13.01 P/E if the $1.78 EPS becomes a reality. After $1.48 actual earnings per share reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 20.27% EPS growth.

Silvercrest Asset Management Group Llc increased Amgen Inc Com (NASDAQ:AMGN) stake by 21,250 shares to 265,097 valued at $46.10M in 2017Q4. It also upped Methode Electrs Inc Com (NYSE:MEI) stake by 300,822 shares and now owns 1.23M shares. Schein Henry Inc Com (NASDAQ:HSIC) was raised too.

MannKind Corporation (NASDAQ:MNKD) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>